These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis. Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563 [TBL] [Abstract][Full Text] [Related]
43. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Abdelbary AA; AbouGhaly MH Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359 [TBL] [Abstract][Full Text] [Related]
44. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940 [TBL] [Abstract][Full Text] [Related]
45. Enhanced penetration and anti-psoriatic efficacy of curcumin by improved smartPearls technology with the addition of glycyrrhizic acid. Jin N; Lin J; Yang C; Wu C; He J; Chen Z; Yang Q; Chen J; Zheng G; Lv L; Liang H; Chen J; Ruan Z Int J Pharm; 2020 Mar; 578():119101. PubMed ID: 32006622 [TBL] [Abstract][Full Text] [Related]
46. Quality-by-Design Approach for Investigating the Efficacy of Tacrolimus and Hyaluronic Acid-Loaded Ethosomal Gel in Dermal Management of Psoriasis: In Vitro, Ex Vivo, and In Vivo Evaluation. Dadwal N; Amisha ; Singh D; Singh A AAPS PharmSciTech; 2023 Nov; 24(8):220. PubMed ID: 37914839 [TBL] [Abstract][Full Text] [Related]
47. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model. Nagle A; Goyal AK; Kesarla R; Murthy RR J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280 [TBL] [Abstract][Full Text] [Related]
48. TPGS assists the percutaneous administration of curcumin and glycyrrhetinic acid coloaded functionalized ethosomes for the synergistic treatment of psoriasis. Guo T; Lu J; Fan Y; Zhang Y; Yin S; Sha X; Feng N Int J Pharm; 2021 Jul; 604():120762. PubMed ID: 34082000 [TBL] [Abstract][Full Text] [Related]
49. Development and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for curcumin transdermal delivery: an anti-inflammatory exposure. Altamimi MA; Kazi M; Hadi Albgomi M; Ahad A; Raish M Drug Dev Ind Pharm; 2019 Jul; 45(7):1073-1078. PubMed ID: 30987466 [TBL] [Abstract][Full Text] [Related]
50. Development and characterisation of clobetasol propionate loaded Squarticles as a lipid nanocarrier for treatment of plaque psoriasis. Dadwal A; Mishra N; Rawal RK; Narang RK J Microencapsul; 2020 Aug; 37(5):341-354. PubMed ID: 32293928 [No Abstract] [Full Text] [Related]
51. Development of flavanone and its derivatives as topical agents against psoriasis: The prediction of therapeutic efficiency through skin permeation evaluation and cell-based assay. Alalaiwe A; Lin CF; Hsiao CY; Chen EL; Lin CY; Lien WC; Fang JY Int J Pharm; 2020 May; 581():119256. PubMed ID: 32220586 [TBL] [Abstract][Full Text] [Related]
52. Anti-psoriatic effect of Lavandula angustifolia essential oil and its major components linalool and linalyl acetate. Rai VK; Sinha P; Yadav KS; Shukla A; Saxena A; Bawankule DU; Tandon S; Khan F; Chanotiya CS; Yadav NP J Ethnopharmacol; 2020 Oct; 261():113127. PubMed ID: 32623016 [TBL] [Abstract][Full Text] [Related]
53. Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity. Meng S; Sun L; Wang L; Lin Z; Liu Z; Xi L; Wang Z; Zheng Y Colloids Surf B Biointerfaces; 2019 Oct; 182():110352. PubMed ID: 31306831 [TBL] [Abstract][Full Text] [Related]
54. Efficient local delivery of FK506 using blocking patches in psoriasis. Zhao Z; Wang H; Yao L; Zhang X; Yu Q; Gu J; Shi Y J Colloid Interface Sci; 2023 Jan; 630(Pt A):676-687. PubMed ID: 36274404 [TBL] [Abstract][Full Text] [Related]
57. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses. Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806 [TBL] [Abstract][Full Text] [Related]
58. Formulation and Evaluation of Resveratrol Loaded Cubosomal Nanoformulation for Topical Delivery. Kurangi B; Jalalpure S; Jagwani S Curr Drug Deliv; 2021; 18(5):607-619. PubMed ID: 32881670 [TBL] [Abstract][Full Text] [Related]
59. Development of Curcumin loaded chitosan polymer based nanoemulsion gel: In vitro, ex vivo evaluation and in vivo wound healing studies. Thomas L; Zakir F; Mirza MA; Anwer MK; Ahmad FJ; Iqbal Z Int J Biol Macromol; 2017 Aug; 101():569-579. PubMed ID: 28322948 [TBL] [Abstract][Full Text] [Related]
60. Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs. Lin YK; Yang SH; Chen CC; Kao HC; Fang JY PLoS One; 2015; 10(9):e0137890. PubMed ID: 26355594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]